Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice

R C Larson1, H Osada, T A Larson

  • 1MRC Laboratory of Molecular Biology, Cambridge, UK.

Oncogene
|September 7, 1995
PubMed
Summary

Aberrant RBTN2 expression, activated by t(11;14) translocation, disrupts T cell differentiation, leading to pre-leukemic changes. This provides a biological basis for RBTN2

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies.

Human reproduction open·2021
Same author

Prematurely ruptured dominant follicles often retain competent oocytes in infertile women.

Scientific reports·2019
Same author

A case of feline gastrointestinal eosinophilic sclerosing fibroplasia limited to the mesentery.

The Journal of small animal practice·2018
Same author

A Novel Cell Line (NCU-L-1) from a Patient with Acute Lymphoblastic Leukemia, FAB, L3, Burkitt's Type.

Leukemia & lymphoma·2016
Same author

Chemical fragment arrays for rapid druggability assessment.

Chemical communications (Cambridge, England)·2016
Same author

Effects on Performance of Interpolated Tasks During the KR Delay or the Post-KR Delay Interval.

Journal of the Japanese Physical Therapy Association = Rigaku ryoho·2015

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • The RBTN2 gene is implicated in T cell leukaemias through the t(11;14) chromosomal translocation.
  • Understanding RBTN2's role in T cell tumorigenesis is crucial for deciphering leukaemia development.

Purpose of the Study:

  • To investigate the role of aberrant RBTN2 expression in T cell differentiation and leukaemogenesis.
  • To explore the consequences of RBTN2 activation in a mouse model.

Main Methods:

  • Utilizing transgenic mice with CD2 or thy1.1 promoters to control RBTN2 expression.
  • Analyzing thymocyte populations during pre-leukaemic and overt leukaemic phases.
  • Assessing T cell differentiation markers (CD4, CD8, CD3, CD45) in thymocytes.

Related Experiment Videos

Main Results:

  • Transgenic mice expressing RBTN2 developed T cell tumours with long latency.
  • Perturbations in T cell differentiation were observed in the thymus during the asymptomatic period.
  • Increased populations of large, CD4/CD8-negative thymocytes and small, CD3/CD45-positive thymocytes were identified.
  • These abnormal thymocyte populations exhibited clonal characteristics.

Conclusions:

  • Aberrant RBTN2 expression directly alters T cell differentiation, preceding overt malignancy.
  • This study provides a biological mechanism linking RBTN2 to T cell leukaemogenesis.
  • The findings suggest RBTN2 plays a significant role in the development of T cell leukaemias following the t(11;14) translocation.